Daunorubicin
Cerubidine, Daunorubicin, Vyxeos (daunorubicin) is a small molecule pharmaceutical. Daunorubicin was first approved as Cerubidine on 1982-01-01. It is used to treat myeloid leukemia acute and precursor cell lymphoblastic leukemia-lymphoma in the USA. It has been approved in Europe to treat myeloid leukemia acute.
| Trade Name | Vyxeos liposomal, known as Vyxeos |
|---|---|
| Common Name | Daunorubicin |
| Indication | myeloid leukemia acute, precursor cell lymphoblastic leukemia-lymphoma |
| Drug Class | Antineoplastic antibiotics (daunorubicin type) |
